The effect of bovine endosteum-derived particles on the proliferation of human mesenchymal stem cells
Source abstract
Abstract
There is a large biomanufacturing and clinical need for cost-effective and simple techniques to expand mesenchymal stem cells whilst retaining their multipotency. Endosteum-derived particles were prepared, characterised and examined as a biomaterial to facilitate the in vitro expansion of human mesenchymal stem cells. Bovine endosteum-derived particles are composed of chondroitin sulphate glycosaminoglycans with 4- and 6-sulphation and N-sulphated heparan sulphate glycosaminoglycans. The particles were positive for perlecan, laminin and fibronectin by immunohistochemistry and alpha-mannose, alpha-glucose, terminal N-acetyl-alpha-D-glucosamine, N-acetyl-alpha-galactosamine and alpha-fucose, using lectin binding. Human mesenchymal stem cells showed greater than 96% attachment to the particles after one day in spinner culture. After 7 days, the stem cells on decalcified particles were viable and had a 5-fold higher growth than the stem cells grown on Cytodex-2 beads. Significantly more stem cells were recovered from decalcified particles compared with mineralised particles (P < 0.05). Differentiation to chondrogenic, osteogenic and adipogenic lineages was maintained after culturing stem cells on the demineralised particles. We conclude that bovine endosteum-derived particles can be extracted from bone marrow to retain sulphated proteoglycans and glycosylated proteins. These particles are a suitable biomaterial for supporting the growth and retaining the multipotency of human mesenchymal stem cells.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesenchymal stem cell research · Proteoglycans and glycosaminoglycans research · Osteoarthritis Treatment and Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Global Stem Cell and Advanced Technologies Market, 2009. Report No.: MKMK2496496.
2. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use
3. Multilineage potential of adult human mesenchymal stem cells10.1126/science.284.5411.143 ↗
4. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit10.1007/s00441-008-0633-5 ↗
5. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta10.1182/blood.V97.5.1227 ↗
6. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction10.1007/s00395-005-0521-z ↗
7. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction10.1161/CIRCULATIONAHA.108.842302 ↗
8. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage10.1016/j.athoracsur.2008.11.057 ↗
9. United States National Institute of Health. ClinicalTrials.gov. Bethesda: Lister Hill National Centre for Biomedical Communications. Online 2009 December. Available from URL: http://www.clinicaltrials.gov/ct2/results?term=mesenchymal+stem+cells&show_down=Y#down
10. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells10.1016/j.joca.2006.08.008 ↗
11. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees10.1053/joca.2001.0504 ↗
12. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports10.3727/000000004783983747 ↗
13. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients10.1016/j.bbmt.2005.02.001 ↗
14. Industrial choices for protein production by large-scale cell culture10.1016/S0958-1669(00)00197-X ↗
15. Complex extracellular matrices promote tissue-specific stem cell differentiation10.1634/stemcells.2002-0109 ↗
16. Wu · Zhongguo Shi Yan Xue Ye Xue Za Zhi · 2003 · 11 · 15
17. Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture10.1016/j.biomaterials.2007.03.015 ↗
18. Expansion and harvesting of hMSC-TERT10.2174/1874120700701010038 ↗
19. Microcarriers in the engineering of cartilage and bone10.1016/j.tibtech.2006.04.009 ↗
20. Evaluating microcarriers for delivering human adult mesenchymal stem cells in bone tissue engineering
21. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ10.1177/002215549804600311 ↗
22. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells10.1182/blood-2004-11-4422 ↗
23. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches10.1182/blood.V97.8.2293 ↗
24. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment10.1182/blood-2005-06-2211 ↗
25. A modified uronic acid carbazole reaction10.1016/0003-2697(62)90095-7 ↗
26. Marrow stromal adipocytes
27. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors10.1182/blood.V84.12.4164.bloodjournal84124164 ↗
28. Cellular methods in cartilage research: primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells10.1016/j.ymeth.2008.01.006 ↗
29. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells10.1006/excr.1997.3858 ↗
30. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow10.1089/ten.1998.4.415 ↗
31. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells10.2106/00004623-199812000-00004 ↗
32. Effects of shear stress on 3-D human mesenchymal stem cell construct development in a perfusion bioreactor system: experiments and hydrodynamic modeling10.1002/bit.21184 ↗
33. The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model10.1002/jbm.820290809 ↗
34. The basement membrane component of biologic scaffolds derived from extracellular matrix10.1089/ten.2006.12.519 ↗
35. Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement10.1089/ten.1996.2.209 ↗
36. Vascular endothelial growth factor in porcine-derived extracellular matrix10.3109/10623320109063154 ↗
37. Identification of extractable growth factors from small intestinal submucosa10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P ↗
38. Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells10.1016/0945-053X(95)90003-9 ↗
39. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan10.1083/jcb.119.4.945 ↗
40. Characterization and functionality of cell surface molecules on human mesenchymal stem cells10.1007/BF02256058 ↗
41. Effects of poly(l-lysine), poly(acrylic acid) and poly(ethylene glycol) on the adhesion, proliferation and chondrogenic differentiation of human mesenchymal stem cells10.1163/156856209X426402 ↗
42. Bone morphogenetic protein 4 induces efficient hematopoietic differentiation of rhesus monkey embryonic stem cells in vitro10.1182/blood.V98.2.335 ↗
43. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity10.1073/pnas.032662199 ↗
44. Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum10.1634/stemcells.2006-0528 ↗
45. Badylak · 2008
46. Livesey · 2003
47. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation10.1073/pnas.78.12.7599 ↗
48. In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone10.1073/pnas.81.11.3419 ↗
49. An extracellular matrix extract for tissue-engineered cartilage10.1109/MEMB.2003.1256275 ↗
50. Expansion of mesenchymal stem cells using a microcarrier-based cultivation system: growth and metabolism10.1002/term.73 ↗